Effect of aspirin on healthspan in community-dwelling older adults: the ASPirin in reducing events in the elderly study
Age and Ageing
•
January 01, 2026
Aspirin does not extend older-adult healthspan
Daily low-dose aspirin did not delay major disease or death in healthy older adults. *Randomized placebo-controlled trial secondary analysis; Level 2 (OCEBM).
- Level of evidence
- Level 2 (OCEBM)
- DocG quality score
- 6.5 / 10
Read the full summary free
Patients, intervention, outcomes, results, and clinical applicability in about 300 words — plus new summaries in your inbox 3× per week.
Sign in with Google
